Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Perifosine and Bortezomib in Relapsed/Refractory Multiple Myeloma
NCT00401011Phase 2Completed
- Sponsor
- COSCIENS Biopharma Inc.
- Start
- Aug 2006
- Primary completion
- Dec 2010
- Modality
- Small Molecules
01
Overview
A Phase 2 trial of perifosine in multiple myeloma (MM), sponsored by COSCIENS Biopharma Inc.. Started Aug 2006; status: completed.
02
Drugs
perifosine
03
Conditions
multiple myeloma (MM)
Beyond the preview
Go deeper on NCT00401011.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00401011.